Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology
R Dewar, O Fadare, H Gilmore… - Archives of pathology …, 2011 - meridian.allenpress.com
Context.—Numerous immunohistochemical stains have been shown to exhibit exclusive or
preferential positivity in breast myoepithelial cells relative to their luminal/epithelial …
preferential positivity in breast myoepithelial cells relative to their luminal/epithelial …
[HTML][HTML] Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer
H Li, F Xu, G Gao, X Gao, B Wu, C Zheng, P Wang, Z Li… - Redox biology, 2020 - Elsevier
Hydrogen sulfide (H 2 S) is considered as a novel second-messenger molecule associated
with the modulation of various physiological and pathological processes. In the field of …
with the modulation of various physiological and pathological processes. In the field of …
Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology
MicroRNAs play important roles in regulating the gene expression and life cycle of cancer
cells. In particular, miR-21, an oncogenic miRNA is a major player involved in tumor …
cells. In particular, miR-21, an oncogenic miRNA is a major player involved in tumor …
[HTML][HTML] Wnt/β-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome
Although Wnt/β-catenin pathway activation has been implicated in mouse models of breast
cancer, there is contradictory evidence regarding its importance in human breast cancer. In …
cancer, there is contradictory evidence regarding its importance in human breast cancer. In …
Delivery of anti-miRNA for triple-negative breast cancer therapy using RNA nanoparticles targeting stem cell marker CD133
Triple-negative breast cancer (TNBC) is an aggressive disease with a short median time
from relapse to death. The increased aggressiveness, drug resistance, disease relapse, and …
from relapse to death. The increased aggressiveness, drug resistance, disease relapse, and …
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
AAN Rose, AA Grosset, Z Dong, C Russo… - Clinical cancer …, 2010 - AACR
Purpose: Although the murine orthologue of glycoprotein nonmetastatic B (GPNMB),
Osteoactivin, promotes breast cancer metastasis in an in vivo mouse model, its importance …
Osteoactivin, promotes breast cancer metastasis in an in vivo mouse model, its importance …
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
B Marty, V Maire, E Gravier, G Rigaill… - Breast Cancer …, 2008 - Springer
Abstract Introduction Basal-like carcinomas (BLCs) and human epidermal growth factor
receptor 2 overexpressing (HER2+) carcinomas are the subgroups of breast cancers that …
receptor 2 overexpressing (HER2+) carcinomas are the subgroups of breast cancers that …
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Background Basal-like constitutes an important molecular subtype of breast cancer
characterised by an aggressive behaviour and a limited therapy response. The outcome of …
characterised by an aggressive behaviour and a limited therapy response. The outcome of …
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer
V Maire, C Baldeyron, M Richardson, B Tesson… - PloS one, 2013 - journals.plos.org
Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC)
associated with the most aggressive clinical behavior. No targeted therapy is currently …
associated with the most aggressive clinical behavior. No targeted therapy is currently …
Breast cancer subtypes: morphologic and biologic characterization
S Masood - Women's Health, 2016 - journals.sagepub.com
Advances in basic science, technology and translational research have created a revolution
in breast cancer diagnosis and therapy. Researchers' discoveries of genes defining …
in breast cancer diagnosis and therapy. Researchers' discoveries of genes defining …